TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Problems
Heavy menstrual bleeding in adolescence
Key Statistics
- 4.8–37% — Prevalence of HMB in adolescence
- 50% — Anovulatory cycles in 1ST year post-menarche
- 47% — MBL reduction with tranexamic acid
Don't-miss facts
-
Admit if bleeding heavily, haemodynamically compromised, or Hb <80 g/dl (children’s unit if under 16)
-
Tranexamic acid first line: 500–1000 mg TDS × up to 4 days (12–17y: 1 g TDS, max 4 g/day) – reduces loss by 47%
-
First-line COCP EE 30 mcg + levonorgestrel 150 mcg; 70–80% amenorrhoea at 1 year if continuous
-
Enzyme inducers (incl. topiramate >200 mg/day) → use LNG-IUS or DMPA. Implant not licensed <18 and not a HMB treatment
-
Acute HMB: packed red cells first line; platelets if <50; oral progestogen (MPA 20 mg TDS) is usual UK first line – standard-dose CHC, not high dose
-
Oral iron for deficiency: elemental iron 3–6 mg/kg (max 200 mg)/day in 2–3 divided doses
-
Norethisterone → metabolised to ethinylestradiol → ↑VTE risk; prefer medroxyprogesterone where CHC contraindicated for VTE
-
Sexual history always taken without the caregiver; chaperone mandatory for any examination; balance confidentiality against safeguarding
Screen for a bleeding disorder if…
HMB from menarche Recurrent epistaxis Excessive bruising Prolonged bleeding post injury/surgery Family history
Anaemia Failure of hormonal therapy
Numbers to know
Menarche 12–13y · cycle 21–45d · period 2–7d ITP = 7% of adolescent HMB PCOS 8–11% of adolescents
SLE: HMB in up to 50% Autoimmune thyroid disease 1 in 3500 children
LNG-IUS: 65% amenorrhoea/reduced loss at 12 months DMPA: 50–60% amenorrhoeic at 12mo, 70% at 24mo
Desogestrel 75 mcg: amenorrhoea in only ⅓–½ at 9–12 months
Abbreviation Key
- HMB — heavy menstrual bleeding
- VWD / vWF — von Willebrand disease / factor
- HPO axis — hypothalamic–pituitary–ovarian axis
- PCOS — polycystic ovary syndrome
- NICE — National Institute for Health and Care Excellence
- ITP — immune thrombocytopenia
- BritSPAG — British Society for Paediatric and Adolescent
- SLE — systemic lupus erythematosus Gynaecology
- CHC / COCP — combined hormonal contraception / combined oral
- UKMEC — UK Medical Eligibility Criteria for Contraceptive Use contraceptive pill
- DMPA — depot medroxyprogesterone acetate
- PT / aPTT — prothrombin / activated partial thromboplastin time
Source: Walter SL, Channing S, Crouch NS. Heavy menstrual bleeding in adolescence: who to investigate and how to manage it. The Obstetrician & Gynaecologist 2024;26:84–94. doi:10.1111/tog.12924
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).